A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean

References 

1. Pan American Health Organization. Towards comprehensive cervical cancer prevention and control: declaration from the regional meeting. Immunization Newsletter. Washington DC: PAHO; June 2008;
2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0. Lyon: IARC Press; 2004;
3. Jara L, Suarez R. Analysis prepared on the economic impact of cervical cancer in Latin America and the Caribbean, 2007. (Unpublished)
4. Castellsagué X, de Sanjosé S, Aguado T, et al. HPV and cervical cancer in the world. Geneva: WHO/ICO Information Centre on HPV and Cervical Cancer; 2007;
5. Luciani S, Winkler J. Cervical cancer prevention in Peru: lessons learned from the TATI demonstration project. Washington: PAHO; 2006;
6. Gage JC, Ferreccio C, Gonzales M, et al. Follow up care of women with abnormal cytology in a low-resource setting. Cancer Detection and Prevention. 2003;27:466–471
   • Abstract
   • Full Text
   • Full-Text PDF (106 KB)
   • CrossRef
7. Agurto I, Arrossi S, White S, et al. Involving the community in cervical cancer prevention programs. International Journal of Gynecology & Obstetrics. 2005;89(Suppl 2):S38–S45
8. World Health Organization. Comprehensive Cervical Cancer Control: A guide to essential practice. Geneva: WHO; 2006;
9. Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia. International Journal of Gynecology and Obstetrics. 2005;89(2):S4–S12
10. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu: a cluster-randomized trial. Lancet. 2007;370:398–406
    • Abstract
    • Full Text
    • Full-Text PDF (175 KB)
    • CrossRef
11. World Health Organization. Human papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Geneva: WHO; 2006;
12. Garnett GP, Kim JJ, French K, et al. Modeling the impact of HPV vaccines on cervical cancer and screening programs. Vaccine. 2006;S3:178–186
13. Goldie S, Diaz M, Constenla D, et al. Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008;26S:L59–L72
14. Andrus JK, Sherris J, Fitzsimmons JW, et al. Introduction of HPV vaccine into developing countries: international strategies for funding and procurement. Vaccine. 2008;26S:K87–K92
15. Andrus JK, Lewis M, Goldie SJ, et al. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine. 2008;26S:L80–L87
16. Andrus JK, Toscano C, Lewis M, et al. A model for enhancing evidenced-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO’s ProVac Initiative. Public Health Reports. 2007;122(6):811–816
17. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992;69(11):2796–2806
    • MEDLINE
    • CrossRef
18. Eifel PJ, Burke TW, Delclos L, et al. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecological Oncology. 1991;41(3):199–205
19. Andrus JK, Fitzsimmons JW. Introduction of new and under-utilized vaccines: sustaining access, disease control, and infrastructure development. PLoS Medicine. 2005;2(10):e286
    • CrossRef
20. Tambini G, Andrus JK, Fitzsimmons JW, et al. Regional programs for health: immunization as a model for strengthening inter-country cooperation and control of infectious diseases. Pan American Journal of Public Health. 2006;20(1):54–59
21. Ecuador National Institute of Statistics and Census. ENDEMAIN Survey. Ecuador: INEC; 2004;
22. Guatemala National Institute of Statistics. Demographic and Health Survey. Guatemala: INE; 2002;